These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35192418)

  • 21. Tracing the origin and evolution of pseudokinases across the tree of life.
    Kwon A; Scott S; Taujale R; Yeung W; Kochut KJ; Eyers PA; Kannan N
    Sci Signal; 2019 Apr; 12(578):. PubMed ID: 31015289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling.
    Locke GA; Muckelbauer J; Tokarski JS; Barbieri CM; Belić S; Falk B; Tredup J; Wang YK
    Methods Enzymol; 2022; 667():685-727. PubMed ID: 35525559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification, crystallization and drug screening of the IRAK pseudokinases.
    Lange SM; Kulathu Y
    Methods Enzymol; 2022; 667():101-121. PubMed ID: 35525539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudokinases: Prospects for expanding the therapeutic targets armamentarium.
    Devang N; Pani A; Rajanikant GK
    Adv Protein Chem Struct Biol; 2021; 124():121-185. PubMed ID: 33632464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
    Rico AB; Linville AC; Olson AT; Wang Z; Wiebe MS
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tale of a tail: The secret behind IGF-1R's oncogenic power.
    Crudden C; Girnita L
    Sci Signal; 2020 May; 13(633):. PubMed ID: 32457114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide-binding mechanisms in pseudokinases.
    Hammarén HM; Virtanen AT; Silvennoinen O
    Biosci Rep; 2015 Nov; 36(1):e00282. PubMed ID: 26589967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease.
    Eyers PA; Keeshan K; Kannan N
    Trends Cell Biol; 2017 Apr; 27(4):284-298. PubMed ID: 27908682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor tyrosine kinases with intracellular pseudokinase domains.
    Mendrola JM; Shi F; Park JH; Lemmon MA
    Biochem Soc Trans; 2013 Aug; 41(4):1029-36. PubMed ID: 23863174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grking the Smoothened signal.
    Sharpe HJ; de Sauvage FJ
    Sci Signal; 2018 Feb; 11(516):. PubMed ID: 29438011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tribbles pseudokinases: novel targets for chemical biology and drug discovery?
    Foulkes DM; Byrne DP; Bailey FP; Eyers PA
    Biochem Soc Trans; 2015 Oct; 43(5):1095-103. PubMed ID: 26517930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For Whom the Bell Tolls: The Structure of the Dead Kinase, IRAK3.
    Horne CR; Murphy JM
    Structure; 2021 Mar; 29(3):197-199. PubMed ID: 33667374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudokinases: update on their functions and evaluation as new drug targets.
    Byrne DP; Foulkes DM; Eyers PA
    Future Med Chem; 2017 Jan; 9(2):245-265. PubMed ID: 28097887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects for pharmacological targeting of pseudokinases.
    Kung JE; Jura N
    Nat Rev Drug Discov; 2019 Jul; 18(7):501-526. PubMed ID: 30850748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR deletions in cell lines for reconstitution studies of pseudokinase function.
    Jacobsen AV; Murphy JM
    Methods Enzymol; 2022; 667():229-273. PubMed ID: 35525543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Ligand Binding to Pseudokinases Using a Thermal Shift Assay.
    Lucet IS; Murphy JM
    Methods Mol Biol; 2017; 1636():91-104. PubMed ID: 28730475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
    Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
    Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein engineering strategies to stimulate the functions of bacterial pseudokinases.
    Yang X; Kowallis KA; Childers WS
    Methods Enzymol; 2022; 667():275-302. PubMed ID: 35525544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.
    Tokarski JS; Zupa-Fernandez A; Tredup JA; Pike K; Chang C; Xie D; Cheng L; Pedicord D; Muckelbauer J; Johnson SR; Wu S; Edavettal SC; Hong Y; Witmer MR; Elkin LL; Blat Y; Pitts WJ; Weinstein DS; Burke JR
    J Biol Chem; 2015 Apr; 290(17):11061-74. PubMed ID: 25762719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.